摘要 |
Compounds of the formula I: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein m, k, B, R<SUP>1</SUP>, R<SUP>2 </SUP>and R<SUP>3 </SUP>are those defined herein, and compositions comprising the same. Also provided are methods for preparing compounds of formula I and using the same in treating p38 mediated disorders in a patient.
|